(NEWT) Newtek Business - Overview
Stock: Banking, Loans, Payments, Insurance, Payroll
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.84% |
| Yield on Cost 5y | 5.30% |
| Yield CAGR 5y | -29.91% |
| Payout Consistency | 64.0% |
| Payout Ratio | 34.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.9% |
| Relative Tail Risk | -4.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.42 |
| Alpha | -2.90 |
| Character TTM | |
|---|---|
| Beta | 1.192 |
| Beta Downside | 1.480 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.31% |
| CAGR/Max DD | -0.10 |
Description: NEWT Newtek Business December 30, 2025
NewtekOne, Inc. (formerly Newtek Business Services Corp.) operates as the holding company for Newtek Bank, NA, delivering a suite of banking, payment-processing, and business-service solutions to U.S. small- and medium-sized enterprises across sectors such as retail, hospitality, assisted-living, and transportation.
As of the most recent 10-K (Q3 2024), the bank reported approximately **$1.4 billion** in total assets, with loan balances up ~7 % YoY driven largely by SBA-guaranteed loans and commercial real-estate financing. Deposits grew ~5 % YoY to roughly **$1.0 billion**, supporting a net interest margin of **3.2 %**, which is modestly above the industry median for community banks but vulnerable to further rate hikes.
The company’s non-bank services-credit/debit card processing, cloud-based POS platforms, payroll, and brokerage-insurance offerings-contribute roughly **30 %** of total revenue, reflecting a diversification trend common in the “bank-as-a-platform” model. However, these lines are sensitive to fintech competition and merchant-price-sensitivity, especially as transaction volumes fluctuate with consumer spending cycles.
Given the reliance on SBA loan pipelines and the broader health of the U.S. small-business sector, investors should monitor **U.S. small-business loan delinquencies** and **Federal Reserve policy** as primary risk drivers; a sustained rise in delinquencies or an aggressive rate-increase cycle could compress margins and increase credit losses.
For a deeper, data-driven view of NewtekOne’s valuation dynamics, you might find ValueRay’s analyst dashboards useful for uncovering hidden upside.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 60.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.19 > 0.02 and ΔFCF/TA -14.50 > 1.0 |
| NWC/Revenue: 46.02% < 20% (prev -326.3%; Δ 372.3% < -1%) |
| CFO/TA -0.19 > 3% & CFO -519.4m > Net Income 60.5m |
| Net Debt (1.93b) to EBITDA (137.5m): 14.07 < 3 |
| Current Ratio: 2.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (25.6m) vs 12m ago -2.45% < -2% |
| Gross Margin: 77.08% > 18% (prev 0.66%; Δ 7642 % > 0.5%) |
| Asset Turnover: 14.34% > 50% (prev 15.48%; Δ -1.14% > 0%) |
| Interest Coverage Ratio: 1.92 > 6 (EBITDA TTM 137.5m / Interest Expense TTM 71.1m) |
Altman Z'' 0.92
| A: 0.06 (Total Current Assets 253.9m - Total Current Liabilities 95.4m) / Total Assets 2.74b |
| B: 0.03 (Retained Earnings 95.0m / Total Assets 2.74b) |
| C: 0.06 (EBIT TTM 136.8m / Avg Total Assets 2.40b) |
| D: 0.04 (Book Value of Equity 95.6m / Total Liabilities 2.35b) |
| Altman-Z'' Score: 0.92 = BB |
Beneish M -3.74
| DSRI: 0.01 (Receivables 438.0k/52.5m, Revenue 344.4m/318.9m) |
| GMI: 0.86 (GM 77.08% / 66.34%) |
| AQI: 0.92 (AQ_t 0.91 / AQ_t-1 0.98) |
| SGI: 1.08 (Revenue 344.4m / 318.9m) |
| TATA: 0.21 (NI 60.5m - CFO -519.4m) / TA 2.74b) |
| Beneish M-Score: -3.74 (Cap -4..+1) = AAA |
What is the price of NEWT shares?
Over the past week, the price has changed by +3.34%, over one month by +16.56%, over three months by +39.10% and over the past year by +13.73%.
Is NEWT a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the NEWT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 16.8 | 20.5% |
| Analysts Target Price | 16.8 | 20.5% |
| ValueRay Target Price | 15.6 | 11.9% |
NEWT Fundamental Data Overview February 03, 2026
P/E Forward = 4.5269
P/S = 1.0128
P/B = 1.142
P/EG = 3.28
Revenue TTM = 344.4m USD
EBIT TTM = 136.8m USD
EBITDA TTM = 137.5m USD
Long Term Debt = 613.2m USD (from longTermDebt, two quarters ago)
Short Term Debt = 135.4m USD (from shortTermDebt, two quarters ago)
Debt = 2.24b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.93b USD (from netDebt column, last quarter)
Enterprise Value = 2.32b USD (388.2m + Debt 2.24b - CCE 310.3m)
Interest Coverage Ratio = 1.92 (Ebit TTM 136.8m / Interest Expense TTM 71.1m)
EV/FCF = -4.47x (Enterprise Value 2.32b / FCF TTM -519.6m)
FCF Yield = -22.38% (FCF TTM -519.6m / Enterprise Value 2.32b)
FCF Margin = -150.9% (FCF TTM -519.6m / Revenue TTM 344.4m)
Net Margin = 17.57% (Net Income TTM 60.5m / Revenue TTM 344.4m)
Gross Margin = 77.08% ((Revenue TTM 344.4m - Cost of Revenue TTM 78.9m) / Revenue TTM)
Gross Margin QoQ = none% (prev 66.06%)
Tobins Q-Ratio = 0.85 (Enterprise Value 2.32b / Total Assets 2.74b)
Interest Expense / Debt = 1.09% (Interest Expense 24.5m / Debt 2.24b)
Taxrate = 20.21% (4.95m / 24.5m)
NOPAT = 109.1m (EBIT 136.8m * (1 - 20.21%))
Current Ratio = 2.66 (Total Current Assets 253.9m / Total Current Liabilities 95.4m)
Debt / Equity = 5.64 (Debt 2.24b / totalStockholderEquity, last quarter 397.6m)
Debt / EBITDA = 14.07 (Net Debt 1.93b / EBITDA 137.5m)
Debt / FCF = -3.72 (negative FCF - burning cash) (Net Debt 1.93b / FCF TTM -519.6m)
Total Stockholder Equity = 349.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.52% (Net Income 60.5m / Total Assets 2.74b)
RoE = 17.30% (Net Income TTM 60.5m / Total Stockholder Equity 349.7m)
RoCE = 14.21% (EBIT 136.8m / Capital Employed (Equity 349.7m + L.T.Debt 613.2m))
RoIC = 10.59% (NOPAT 109.1m / Invested Capital 1.03b)
WACC = 2.26% (E(388.2m)/V(2.63b) * Re(10.31%) + D(2.24b)/V(2.63b) * Rd(1.09%) * (1-Tc(0.20)))
Discount Rate = 10.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.03%
Fair Price DCF = unknown (Cash Flow -519.6m)
EPS Correlation: 19.26 | EPS CAGR: -2.69% | SUE: -0.47 | # QB: 0
Revenue Correlation: 89.82 | Revenue CAGR: 27.79% | SUE: 1.57 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.47 | Chg30d=+0.020 | Revisions Net=+0 | Analysts=4
EPS current Year (2026-12-31): EPS=2.35 | Chg30d=+0.072 | Revisions Net=+0 | Growth EPS=+7.8% | Growth Revenue=+16.4%
EPS next Year (2027-12-31): EPS=2.52 | Chg30d=+0.107 | Revisions Net=+0 | Growth EPS=+7.1% | Growth Revenue=+13.6%